A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin

被引:206
作者
Browne, GJ [1 ]
Proud, CG [1 ]
机构
[1] Univ Dundee, Div Mol Physiol, Fac Life Sci, Dundee DD1 5EH, Scotland
关键词
D O I
10.1128/MCB.24.7.2986-2997.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eukaryotic elongation factor 2 (eEF2) kinase is an unusual calcium- and calmodulin-dependent protein kinase that is regulated by insulin through the rapamycin-sensitive mTOR pathway. Here we show that insulin decreases the ability of eEF2 kinase to bind calmodulin in a rapamycin-sensitive manner. We identify a novel phosphorylation site in eEF2 kinase (Ser78) that is located immediately next to its calmodulin-binding motif. Phosphorylation of this site is increased by insulin in a rapamycin-sensitive fashion. Regulation of the phosphorylation of Ser78 also requires amino acids and the protein kinase phosphoinositide-dependent kinase 1. Mutation of this site to alanine strongly attenuates the effects of insulin and rapamycin both on the binding of calmodulin to eEF2 kinase and on eEF2 kinase activity. Phosphorylation of Ser78 is thus likely to link insulin and mTOR signaling to the control of eEF2 phosphorylation and chain elongation. This site is not a target for known kinases in the mTOR pathway, e.g., the S6 kinases, implying that it is phosphorylated by a novel mTOR-linked protein kinase that serves to couple hormones and amino acids to the control of translation elongation. eEF2 kinase is thus a target for mTOR signaling independently of previously known downstream components of the pathway.
引用
收藏
页码:2986 / 2997
页数:12
相关论文
共 52 条
  • [1] The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1 beta (Rsk-2) and p70 S6 kinase
    Alessi, DR
    [J]. FEBS LETTERS, 1997, 402 (2-3) : 121 - 123
  • [2] 3 Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
    Alessi, DR
    Kozlowski, MT
    Weng, QP
    Morrice, N
    Avruch, J
    [J]. CURRENT BIOLOGY, 1998, 8 (02) : 69 - 81
  • [3] A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
    Aoki, M
    Blazek, E
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 136 - 141
  • [4] Avruch J, 2001, Prog Mol Subcell Biol, V26, P115
  • [5] Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms
    Balendran, A
    Hare, GR
    Kieloch, A
    Williams, MR
    Alessi, DR
    [J]. FEBS LETTERS, 2000, 484 (03) : 217 - 223
  • [6] Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides
    Beauloye, C
    Marsin, AS
    Bertrand, L
    Krause, U
    Hardie, DG
    Vanoverschelde, JL
    Hue, L
    [J]. FEBS LETTERS, 2001, 505 (03) : 348 - 352
  • [7] Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability
    Beugnet, A
    Tee, AR
    Taylor, PM
    Proud, CG
    [J]. BIOCHEMICAL JOURNAL, 2003, 372 : 555 - 566
  • [8] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [9] Regulation of peptide-chain elongation in mammalian cells
    Browne, GJ
    Proud, CG
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (22): : 5360 - 5368
  • [10] BROWNE GJ, 2004, J BIOL CHEM